Search hospitals > Wisconsin > Milwaukee
Aurora Saint Luke's Medical Center
Claim this profileMilwaukee, Wisconsin 53215
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Ovarian Cancer
459 reported clinical trials
39 medical researchers
Summary
Aurora Saint Luke's Medical Center is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Aurora Saint Luke's Medical Center is involved with conducting 459 clinical trials across 569 conditions. There are 39 research doctors associated with this hospital, such as Thomas J. Saphner, Rubina Qamar, Antony Ruggeri, and Sigrun Hallmeyer, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage II
Stage III
2Breast Cancer
Global LeaderHER2 negative
ER positive
PR positive
Top PIs
Thomas J. SaphnerAurora Saint Luke's Medical Center2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
30 reported clinical trials
68 drugs studied
Rubina QamarAurora Saint Luke's Medical Center5 years of reported clinical research
Studies Breast Cancer
Studies Lung Cancer
24 reported clinical trials
68 drugs studied
Antony RuggeriAurora Cancer Care-Milwaukee West5 years of reported clinical research
Studies Pancreatic Cancer
Studies Colon Cancer
14 reported clinical trials
57 drugs studied
Sigrun Hallmeyer, MDAdvocate Lutheran General Hospital2 years of reported clinical research
Studies Breast Cancer
Studies Cancer
13 reported clinical trials
23 drugs studied
Clinical Trials running at Aurora Saint Luke's Medical Center
Lung Cancer
Breast Cancer
Ovarian Cancer
Bladder Cancer
Prostate Cancer
Cancer
Breast cancer
Esophageal cancer
Non-Small Cell Lung Cancer
Kidney Cancer
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Aurora Saint Luke's Medical Center?
Aurora Saint Luke's Medical Center is a medical facility located in Milwaukee, Wisconsin. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Aurora Saint Luke's Medical Center is involved with conducting 459 clinical trials across 569 conditions. There are 39 research doctors associated with this hospital, such as Thomas J. Saphner, Rubina Qamar, Antony Ruggeri, and Sigrun Hallmeyer, MD.
Where is Aurora Saint Luke's Medical Center located?
**Aurora St. Luke's Medical Center**
- **Address:** 2900 W Oklahoma Ave, Milwaukee, WI 53215
- **Directions:** From I-43 N, take the I-94 E exit. Continue on I-94 E to W Oklahoma Ave in Milwaukee. Take exit 309B from I-94 E, and the hospital will be on your left.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Aurora Saint Luke's Medical Center, contact Aurora Health Care at 800-326-2250 or visit [www.aurorahealthcare.org/patient-visitors/billing-payment/financial-assistance](http://www.aurorahealthcare.org/patient-visitors/billing-payment/financial-assistance). For insurance inquiries, call 833-528-7672 or visit [www.advocateaurorahealth.org/contact-us/](http://www.advocateaurorahealth.org/contact-us/).
What insurance does Aurora Saint Luke's Medical Center accept?
Aurora Saint Luke's Medical Center accepts a wide range of insurance plans, such as Medicare, in-state Medicaid, Tricare, and Blue Cross/Blue Shield, among others. It is crucial to confirm with your insurance provider that St. Luke's is in-network and your plan covers the intended services.
What awards or recognition has Aurora Saint Luke's Medical Center received?
**Aurora Saint Luke's Medical Center, Milwaukee, Wisconsin**
- Recognized for research excellence, notably at the eighth annual Research Recognition Event.
- Contributed to significant studies, including two heart valve replacement studies with encouraging results.
- Achieved Magnet recognition, underscoring a commitment to nursing excellence and high-quality patient care.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.